195 related articles for article (PubMed ID: 38017415)
21. Progress in global measles control, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
[TBL] [Abstract][Full Text] [Related]
22. The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review.
Hughes SL; Bolotin S; Khan S; Li Y; Johnson C; Friedman L; Tricco AC; Hahné SJM; Heffernan JM; Dabbagh A; Durrheim DN; Orenstein WA; Moss WJ; Jit M; Crowcroft NS
Vaccine; 2020 Jan; 38(3):460-469. PubMed ID: 31732326
[TBL] [Abstract][Full Text] [Related]
23. Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland.
Edelstein M; White J; Bukasa A; Saliba V; Ramsay M
Bull World Health Organ; 2019 Nov; 97(11):754-763. PubMed ID: 31673191
[TBL] [Abstract][Full Text] [Related]
24. Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.
Hagan JE; Kriss JL; Takashima Y; Mariano KML; Pastore R; Grabovac V; Dabbagh AJ; Goodson JL
MMWR Morb Mortal Wkly Rep; 2018 May; 67(17):491-495. PubMed ID: 29723171
[TBL] [Abstract][Full Text] [Related]
25. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
[TBL] [Abstract][Full Text] [Related]
26. Progress Toward Measles Elimination - African Region, 2013-2016.
Masresha BG; Dixon MG; Kriss JL; Katsande R; Shibeshi ME; Luce R; Fall A; Dosseh ARGA; Byabamazima CR; Dabbagh AJ; Goodson JL; Mihigo R
MMWR Morb Mortal Wkly Rep; 2017 May; 66(17):436-443. PubMed ID: 28472026
[TBL] [Abstract][Full Text] [Related]
27. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
28. Measles vaccine coverage and series completion among children 0-8 years of age in Tianjin, China.
Montgomery JP; Zhang Y; Carlson B; Ewing S; Wang X; Boulton ML
Pediatr Infect Dis J; 2015 Mar; 34(3):289-95. PubMed ID: 25259932
[TBL] [Abstract][Full Text] [Related]
29. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].
Limia Sánchez A; Molina Olivas M
Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791
[TBL] [Abstract][Full Text] [Related]
30. Suboptimal MMR2 vaccine coverage in six counties in Norway detected through the national immunisation registry, April 2014 to April 2017.
Hagerup-Jenssen M; Kongsrud S; Riise ØR
Euro Surveill; 2017 Apr; 22(17):. PubMed ID: 28489000
[TBL] [Abstract][Full Text] [Related]
31. Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.
Wang D; Nie T; Pan F; Wang Y; Wang J; Qin W
Hum Vaccin Immunother; 2021 Jul; 17(7):2072-2077. PubMed ID: 33545016
[No Abstract] [Full Text] [Related]
32. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
[TBL] [Abstract][Full Text] [Related]
33. Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia.
Lawrence GL; MacIntyre CR; Hull BP; McIntyre PB
Aust N Z J Public Health; 2003; 27(4):413-8. PubMed ID: 14705304
[TBL] [Abstract][Full Text] [Related]
34. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
35. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.
Ma C; Li F; Zheng X; Zhang H; Duan M; Yang Y; Hao L; Su Q; Rodewald L; Guo B; Xiao S; Wang H; Li L; Li J; Luo H; Gao L
BMC Infect Dis; 2015 Jan; 15():23. PubMed ID: 25608672
[TBL] [Abstract][Full Text] [Related]
36. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
[TBL] [Abstract][Full Text] [Related]
37. Elimination of measles--South Korea, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(13):304-7. PubMed ID: 17410083
[TBL] [Abstract][Full Text] [Related]
38. Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China.
Yin Z; Wen T; Fang Q; Zheng C; Gong X; Li J; Wang S; Xiang Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2086774. PubMed ID: 35675040
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
Hu Y; Chen Y; Wang Y; Liang H
Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
[TBL] [Abstract][Full Text] [Related]
40. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
